- Home
- INVA vs CHY Comparison
INVA vs CHY Comparison
Compare INVA & CHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVA
- CHY
- Stock Information
- Founded
- INVA 1996
- CHY 2003
- Country
- INVA United States
- CHY United States
- Employees
- INVA N/A
- CHY N/A
- Industry
- INVA Biotechnology: Pharmaceutical Preparations
- CHY Investment Managers
- Sector
- INVA Health Care
- CHY Finance
- Exchange
- INVA Nasdaq
- CHY Nasdaq
- Market Cap
- INVA 1.1B
- CHY 934.9M
- IPO Year
- INVA 2004
- CHY N/A
- Fundamental
- Price
- INVA $18.08
- CHY $11.06
- Analyst Decision
- INVA Buy
- CHY
- Analyst Count
- INVA 1
- CHY 0
- Target Price
- INVA N/A
- CHY N/A
- AVG Volume (30 Days)
- INVA 436.3K
- CHY 128.3K
- Earning Date
- INVA 03-07-2025
- CHY 01-01-0001
- Dividend Yield
- INVA N/A
- CHY 10.11%
- EPS Growth
- INVA 46.55
- CHY N/A
- EPS
- INVA 0.99
- CHY N/A
- Revenue
- INVA $352,745,000.00
- CHY N/A
- Revenue This Year
- INVA $16.20
- CHY N/A
- Revenue Next Year
- INVA N/A
- CHY N/A
- P/E Ratio
- INVA $18.25
- CHY N/A
- Revenue Growth
- INVA 21.46
- CHY N/A
- 52 Week Low
- INVA $14.33
- CHY $9.97
- 52 Week High
- INVA $21.28
- CHY $12.16
- Technical
- Relative Strength Index (RSI)
- INVA 45.13
- CHY 30.00
- Support Level
- INVA $17.92
- CHY $11.26
- Resistance Level
- INVA $18.20
- CHY $11.43
- Average True Range (ATR)
- INVA 0.26
- CHY 0.12
- MACD
- INVA -0.04
- CHY -0.00
- Stochastic Oscillator
- INVA 33.33
- CHY 4.06
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
About CHY Calamos Convertible and High Income Fund
Calamos Convertible & High Income Fund is a diversified, closed-end management investment company. Its objective is to provide total return through a combination of capital appreciation and current income. The firm invests in a diversified portfolio of convertible securities and high yield securities.